Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

POWERED WHEELCHAIRS MUST PROVIDE EMI WARNINGS

This article was originally published in The Gray Sheet

Executive Summary

POWERED WHEELCHAIRS MUST PROVIDE EMI WARNINGS, FDA says in a recent letter to manufacturers of powered wheelchairs, scooters and components or accessories for the devices. The labeling, which must be affixed to devices shipped after Dec. 2, should include an explanation of electromagnetic interference, how to avoid risks associated with it, warnings that accessories or components may compound risks associated with EMI, and statements detailing the level of the device's immunity to EMI, according to the letter. For products already on the market, FDA says the information should be "supplied to consumers as soon as it is feasible."

Latest Headlines
See All
UsernamePublicRestriction

Register

MT002562

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel